Immutep Ltd share price logo

Immutep Ltd Share Price

NASDAQ: IMMP

Small Cap

$0.42

(+-0.08%)

as on

Immutep Ltd Stock Performance

as on March 20, 2026 at 6:58 am IST

  • Day's Low

    $0.39
    $0.42
    downward going graph

    7.14%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.39
    $3.53
    downward going graph

    6.71%

    Downside

    740.45%

    Upside

    downward going graph

Immutep Ltd share price movements today

Previous Close
$0.42
Open
$0.41
Volume
1.4M
Day's Low - High
$0.39 - $0.42
52 Week Low - High
$0.39 - $3.53

Immutep Ltd Historical Returns

1 Month Return
-85.21 %
3 Month Return
-84.31 %
1 Year Return
-78.28 %
3 Year Return
-77.08 %
5 Year Return
-86.15 %

Immutep Ltd Stock Fundamentals & Key Indicators

Check Immutep Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$61.2M

EPS (TTM)

-0.1311

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-82.4M

Revenue (TTM)

7.9M

Profit Margin

0.00%

Return On Equity TTM

-61.85%

Immutep Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immutep Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Immutep Ltd image
Immutep Ltd
BUY$61.2M-86.15%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.7B115.8%135.118.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$114.7B111.95%29.532.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.4BNA114.755.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.7B55.68%17.9531.41%

Stock Returns calculator for Immutep Ltd Stock including INR - Dollar returns

The Immutep Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immutep Ltd investment value today

Current value as on today

₹30,067

Returns

₹69,933

(-69.93%)

Returns from Immutep Ltd Stock

₹77,895 (-77.89%)

Dollar Returns*

₹7,962 (+7.96%)

Analyst Recommendation on Immutep Ltd Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Immutep Ltd. Average target price of $1

Immutep Ltd Share Price Target

Get share price movements and forecasts by analysts on Immutep Ltd.

What analysts predicted

58%UPSIDE

Target Price

$1

Current Price

$0.42

Analyzed by

9 Analysts

Target

$1.00

Immutep Ltd target price $1, a slight upside of 58% compared to current price of $0.42. According to 9 analysts rating.

Immutep Ltd Stock’s Investor Sentiment and Interest

Investment in Immutep Ltd Shares on INDmoney has grown by 3433.33% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:3433.33% versus previous 30 day period

Search interest for Immutep Ltd Stock has increased by 376% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:376% versus previous 30 day period

Immutep Ltd Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Sep 2023
Dec 2023
Jun 2024
Sep 2024
Dec 2024
Jun 2025
Dec 2025
Total Revenue
1
1
2
1
1
3
1
6
Gross Profit
0
0
1
-19
-19
-22
-34
-40
Operating Income
-23
-21
-43
-44
-44
-51
-74
-46
EBITDA
-20
-19
-22
-22
-22
-26
-36
-44
Interest Expense
0
0
0
0
0
-
-
0
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
-20
-19
-21
-21
-21
-22
-39
-44
Income Tax Expense
0
0
0
21
21
-
-
-
Net Income
-13
-19
-21
-21
-21
-22
-39
-44
Net Profit Margin
-1223.54%
-1058.85%
-1005.72%
-1241.29%
-1241.29%
-710.92%
-2059.84%
-744.36%

Immutep Ltd Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
0
3
1
0
5
2
0
2
2
5
Gross Profit
-5
1
-5
-11
-10
-10
-1
0
-25
-56
Operating Income
-61
-9
-11
-20
-16
-31
-33
-77
-88
-126
EBITDA
-61
-8
-10
-16
-11
-17
-31
-39
-44
-62
Interest Expense
0
-
-
-
0
0
0
0
0
-
Depreciation
-
1
1
1
2
2
2
-
-
-
Income Before Tax
-63
-10
-12
-18
-13
-29
-32
-39
-42
-61
Income Tax Expense
-1
0
0
-2
0
0
0
0
0
-
Net Income
-45
-7
-9
-11
-9
-22
-22
-26
-28
-61
Net Profit Margin
-35426.72%
-221.89%
-484.55%
-11640.01%
-179.90%
-774.12%
-18906.51%
-1138.04%
-1111.87%
-1218.02%

Immutep Ltd Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Dec 2025
Net Income
-19
-21
-
-21
-21
-22
-
-39
-44
Operating Cash Flow
-17
-17
-
-16
-7
-28
-
-33
-28
Investing Cash Flow
0
0
-
-
-20
-30
-
24
34
Financing Cash Flow
38
0
0
95
95
0
0
0
0
Change in Cash
68
-6
-8
58
66
-46
-
-73
6

Immutep Ltd Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-9
-12
-18
-13
-29
-32
-39
-42
-61
Operating Cash Flow
-8
-7
-15
-10
-17
-30
-35
-34
-62
Investing Cash Flow
0
0
0
0
0
0
0
-21
-38
Financing Cash Flow
0
18
8
20
52
50
76
95
0
Change in Cash
-8
11
-6
9
34
19
43
38
-94

Global Institutional Holdings in Immutep Ltd

Funds
Holdings
BlackRock Inc
0.39%
Meridian Wealth Management, LLC
0.31%
Susquehanna International Group, LLP
0.05%
Verition Fund Managegment, LLC
0.04%
LPL Financial Corp
0.02%
See all

Immutep Ltd News & Key Events

    Insights on Immutep Ltd

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 1.89M → 6.02M (in $), with an average increase of 68.5% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 65.9% return, outperforming this stock by 143.0%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 22.7% return, outperforming this stock by 101.0%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 7 quarters, -19.27M → -44.85M (in $), with an average decrease of 17.5% per quarter

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, IMMP stock has moved down by -14.9%

    About Immutep Ltd

    immutep is a globally active biotechnology company, listed on the australian stock exchange and on the nasdaq global market in the us. as a leader in personalized bio-therapeutic products for cancer, immutep is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders. immutep's main pipeline of products is based on the lag-3 immune control mechanism which plays a vital role in the regulation of the t cell immune response. the most clinically advanced product is a t cell immunostimulatory factor (apc activator), imp321, for cancer chemoimmunotherapy which has completed early phase ii trials. a number of additional lag-3 products including antibodies for immune response modulation in autoimmunity and cancer are being developed by large pharmaceutical partners.
    OrganisationImmutep Ltd
    HeadquartersAustralia Square, Sydney, NSW, Australia, 2000
    IndustryHealth Technology
    CEOMr. Marc Voigt
    E-voting on sharesClick here to vote

    Key Management of Immutep Ltd

    Name

    Title

    Mr. Marc Voigt

    CEO, MD, CFO, Chief Business Officer & Executive Director

    Ms. Deanne Miller LLB

    COO, General Counsel & Joint Company Secretary

    Dr. Frederic Triebel M.D., Ph.D.

    Chief Scientific Officer & Executive Director

    Mr. Christian Mueller BBA, MSc.

    Chief Development Officer

    Dr. Stephan Winckels M.D., Ph.D.

    Chief Medical Officer

    Ms. Indira Naidu

    Joint Company Secretary

    FAQs

    What is Immutep Ltd share price today?

    Immutep Ltd share price today is $0.42 as on at the close of the market. Immutep Ltd share today touched a day high of $0.42 and a low of $0.39.

    What is the 52 week high and 52 week low for Immutep Ltd share?

    Immutep Ltd share touched a 52 week high of $3.53 on and a 52 week low of $0.39 on . Immutep Ltd stock price today i.e. is closed at $0.42,which is 88.10% down from its 52 week high and 7.20% up from its 52 week low.

    What is Immutep Ltd's market capitalisation today?

    Immutep Ltd market capitalisation is $0.00T as on .

    How to invest in Immutep Ltd Stock (IMMP) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Immutep Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immutep Ltd Shares that will get you 3.5714 shares as per Immutep Ltd share price of $0.42 per share as on March 20, 2026 at 1:28 am IST.

    What is the minimum amount required to buy Immutep Ltd Stock (IMMP) from India?

    Indian investors can start investing in Immutep Ltd (IMMP) shares with as little as ₹93.193 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹931.93 in Immutep Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Immutep Ltd share’s latest price of $0.42 as on March 20, 2026 at 1:28 am IST, you will get 23.8095 shares of Immutep Ltd. Learn more about fractional shares .

    What are the returns that Immutep Ltd has given to Indian investors in the last 5 years?

    Immutep Ltd stock has given -86.15% share price returns and 27.41% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?